PharmaResources (Shanghai) Co. Ltd. A Tangible Net Worth Ratio
PharmaResources (Shanghai) Co. Ltd. A tangible net worth ratio. PharmaResources (Shanghai) Co. Ltd. A (301230) has a Tangible Net Worth Ratio of 99.2% as of March 2026. This metric is calculated by deducting intangible assets (CN¥8.50 Million) from net assets (CN¥1.03 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See net asset quality index of PharmaResources (Shanghai) Co. Ltd. A to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of PharmaResources (Shanghai) Co. Ltd. A (2020–2025)
Tangible net worth ratio of PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025. This chart shows how PharmaResources (Shanghai) Co. Ltd. A's Tangible Net Worth Ratio has changed across 6 annual periods from 2020 to 2025. As of March 2026, the ratio stands at 99.2%, reflecting net assets of CN¥1.03 Billion with intangible assets of CN¥8.50 Million CNY. See PharmaResources (Shanghai) Co. Ltd. A (301230) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
PharmaResources (Shanghai) Co. Ltd. A Tangible Net Worth Ratio by Year (2020–2025)
PharmaResources (Shanghai) Co. Ltd. A tangible net worth ratio by year from 2020 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for PharmaResources (Shanghai) Co. Ltd. A from 2020 to 2025, covering 6 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see PharmaResources (Shanghai) Co. Ltd. A stock valuation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.1% | CN¥1.00 Billion | CN¥8.62 Million | CN¥1.31 Billion | ▼ 0.0 pp |
| 2024 | 99.2% | CN¥1.03 Billion | CN¥8.49 Million | CN¥1.32 Billion | ▼ 0.0 pp |
| 2023 | 99.2% | CN¥1.12 Billion | CN¥8.71 Million | CN¥1.49 Billion | ▼ 0.0 pp |
| 2022 | 99.3% | CN¥1.11 Billion | CN¥8.25 Million | CN¥1.30 Billion | ▲ +1.5 pp |
| 2021 | 97.7% | CN¥348.44 Million | CN¥7.94 Million | CN¥557.81 Million | ▲ +0.8 pp |
| 2020 | 96.9% | CN¥263.18 Million | CN¥8.08 Million | CN¥373.99 Million | — |